Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Integrin function in osteoclasts

S B Rodan1, G A Rodan

  • 1Department of Bone Biology and Osteoporosis Research, Merck Research Laboratories, West Point, Pennsylvania 19486, USA.

The Journal of Endocrinology
|October 24, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alendronate: preclinical studies.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity.

Prostaglandins, leukotrienes, and essential fatty acids·2006
Same author

Preservation of thoracic spine microarchitecture by alendronate: comparison of histology and microCT.

Bone·2005
Same author

Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins.

Cell death and differentiation·2004
Same author

Disposition of a novel and potent alpha(v)beta3 antagonist in animals, and extrapolation to man.

Xenobiotica; the fate of foreign compounds in biological systems·2004
Same author

M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase.

Cell death and differentiation·2003
Same journal

Chronic hyperinsulinemia accelerates adipose senescence via mitochondrial dysfunction and cGAS-STING signalling.

The Journal of endocrinology·2026
Same journal

Probiotic Lactobacillus reuteri KUB-AC5 provides cardioprotection via mitigating cardiac mitochondrial dysfunction in obese rats.

The Journal of endocrinology·2026
Same journal

Relationship between hypothalamic astrocytes and gonadotropin-releasing hormone neurons in the female plains vizcacha.

The Journal of endocrinology·2026
Same journal

Passive exercise failed to reverse OVX-induced bone microstructural degeneration to the extent achieved by HRT.

The Journal of endocrinology·2026
Same journal

Downregulation of SLC32A1 mediates the PAI-1 pathway in alleviating hepatic stellate cell activation and liver fibrosis.

The Journal of endocrinology·2026
Same journal

Triiodothyronine-driven pro-inflammatory responses of dendritic cells are restrained by sphingolipid signaling.

The Journal of endocrinology·2026
See all related articles

Integrins, like alpha v beta 3, are key cell receptors involved in bone resorption. Targeting these receptors with RGD peptides can inhibit bone breakdown, offering insights into bone metabolism.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Orthopedics

Background:

  • Integrins are cell surface receptors mediating cell adhesion and signaling.
  • The alpha v beta 3 integrin is highly expressed in osteoclasts, the cells responsible for bone resorption.
  • Osteoclast integrins interact with extracellular matrix proteins containing the RGD tripeptide.

Purpose of the Study:

  • To investigate the role of osteoclast integrins in bone resorption.
  • To understand the signaling pathways involved in osteoclast-matrix interactions.
  • To explore potential therapeutic targets for modulating bone metabolism.

Main Methods:

  • Studied integrin expression in osteoclasts.
  • Utilized RGD peptides, antibodies, and RGD-containing proteins to inhibit bone resorption in vitro and in vivo.

Related Experiment Videos

  • Investigated intracellular signaling events, including calcium transients and kinase activity.

    • Main Results:

    • Alpha v beta 3 integrin binds RGD-containing proteins abundant in bone, such as osteopontin.
    • Inhibition of alpha v beta 3 and RGD-containing proteins significantly reduced bone resorption.
    • RGD peptides modulated calcium transients and associated with phosphatidylinositol 3-kinase and pp60c-src.
    • Alpha v and beta 3 gene expression is regulated by 1,25(OH)2D3 and cytokines.

    Conclusions:

    • Osteoclast integrins, particularly alpha v beta 3, play a crucial role in bone resorption.
    • Targeting RGD-binding integrins offers a potential strategy for treating bone metabolic disorders.
    • Further research into osteoclast integrin-matrix interactions can elucidate bone resorption mechanisms.